ReviewBioImpacts : BI2026

Integrin-linked kinase (ILK) in hematologic malignancies: Bridging molecular mechanisms to therapeutic innovation.

Omer Qutaiba B Allela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.